ASCO Highlights

flipper_slider

Editor's Choice

Prof. Martin Reck explains the latest data from the CheckMate 017 and 057 trials of nivolumab in NSCLC. He also discusses new strategies for immunotherapy is NSCLC. FILMED AT THE AMERICAN SOCIETY OF CLINICAL...

ASCO Highlights Videos

Prof. Christian Rolfo describes the importance of molecular profiling in cancer patients, and the addition of liquid biopsy. Support: The filming of this video was supported by Prometheus. FILMED AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING, JUNE 2016 CAN YOU DESCRIBE...
Prof. Martin Reck explains the latest data from the CheckMate 017 and 057 trials of nivolumab in NSCLC. He also discusses new strategies for immunotherapy is NSCLC. FILMED AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING, JUNE 2016 CAN YOU TELL US ABOUT THE LATEST DATA FROM...
Dr. Howard Kaufman discusses the key findings of the PROCLAIM Registry and IL-2. FILMED AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING, JUNE 2016 COULD YOU GIVE US AN OVERVIEW OF THE RATIONALE BEHIND THE PROCLAIM REGISTRY? 00:10 – The Proclaim Registry was really designed...
Dr. Ajjai Alva discusses IL-2 and the current treatment landscape for renal cell carcinoma and metastatic melanoma. Disclosure: Dr Alva served on an Advisory Board with Prometheus in 2015. Support: The filming of this video was supported by Prometheus. FILMED AT THE AMERICAN SOCIETY OF...
Dr. Nicola Fazio explains the findings of the RADIANT-4 Trial and discusses mTOR inhibition in neuroendocrine tumors. FILMED AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING, JUNE 2016 CAN YOU TELL US ABOUT THE FINDINGS OF THE RADIANT-4 TRIAL? 00:09 – The RADIANT-4 trial was...
Patrick Schoffski and Prof. John Crown discuss eribulin in breast cancer and advanced liposarcoma. This covers data presented at ASCO 2016 and the importance of the overall survival benefit demonstrated in these two tumours. FILMED AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING...